Objective To investigate the spatial and temporal regulation effect of VEGF on human fetal retinal vascularization and angiogenesis. Methods The posterior segmental retinas from 54 human fetuses of the 9th week to the 40th week were studied by immunohistodhemistry standing for the expressions of VEGF and PCNA. Results 1. The distribution of VEGF espression was spiking and the peaks were during the 9th-13th and around the 26th week. 2. PCNA immunoreactivity was localized in spindle cells and vascular endothelial cells. The expression level was fluctuated during the developmental process. The peaks were during the 9th-13th and around the 21st week. In these periods, the spindle cells kept proliferating and differentiating, and remodelled subsequently to form the inner side retinal vessels. From the 26th or 34th week, the PCNA immununoreactivity is fully expressed in the vascular endothelial cells of the inner and outer margin of inner nuclear layer(INL) and kept to full terms. 3. Significant positive correlation were shown between the content of VEGF in the retina and that of PCNA in spindle cells and vascular endothelial cells(r=0.736,p＜0.01). Conclusion VEGF was positively involved in modulating human fetal retinal vascularization and angiogenesis. (Chin J Ocul Fundus Dis,1999,15:12-15)
Purpose To observe the expression of proliferating cell nuclear antigen（PCNA）and bcl-2 of cultured human retinal pigment epithelial cells（RPE）． Methods SABC techniques were applied for immunocytochemical staining of cultured RPE with mouse anti-human PCNA monoclonal antibody and rabbit antihuman bcl-2 antibodies． Results 31.2% and 50.6% cultured cells were positive to anti-human PCNA at 24h and 48h after seeding，respectively．The positive staining was mottled in the nucleus．positive staining for bcl was seen in 76%to 90% cells as fine granules scattered within the cytoplasm. Conclusion One half of cultured RPE expressed PCNA，indicating that the cells were in phase S of the cell cycle．Positive staining for bcl-2 appeared in much more RPE cells．These biological markers may be associated with the growth activity of cultured RPE． (Chin J Ocul Fundus Dis,1998,14:26-28)
目的:初步探讨伽玛刀治疗前后复发胶质母细胞瘤中P53及PCNA蛋白表达的变化及其临床意义。方法:用免疫组化SP法检测29例复发胶质母细胞瘤患者(伽玛刀刀治疗组12例,非伽玛刀治疗组17例)在初发和复发的肿瘤组织中P53蛋白和PCNA蛋白的表达。结果:两组患者在性别,年龄,肿瘤部位及大小构成上差异无统计学意义(Pgt;0.05);两组的复发时间的差异有统计学意义(P=0.0409lt;0.05);在伽玛刀治疗组P53及PCNA蛋白在复发胶质母细胞瘤中表达明显降低(p53,t=3.915,P=0.02lt;0.05;PCNA,t=2.962,P=0.013lt;0.05);非伽玛刀治疗组p53及PCNA蛋白在复发胶质母细胞瘤中表达明显增加(p53,t=-5.926,P=0.000lt;0.05;PCNA,t=-5.160,P=0.000lt;0.05);P53及PCNA蛋白在伽玛刀治疗组和非伽玛刀治疗组的表达变化有统计学意义(p53,t=-5.577,P=0.000lt;0.05PCNA,t=-5.542,P=0.000lt;0.05);在伽玛刀治疗组及非伽玛刀治疗组,P53蛋白和PCNA蛋白的阳性表达率不存在明显的相关性(伽玛刀治疗组,r=-0.085,P=0.792gt;0.05非伽玛刀治疗组,r=0.450,P=0.07gt;0.05)。结论:P53及PCNA蛋白的异常表达与胶质母细胞瘤的复发有关,伽玛刀治疗胶质母细胞瘤瘤可能通过抑制P53及PCNA蛋白表达而起作用。
摘要:目的: 探讨PCNA,VEGF在胃癌组织中的表达关系及其意义。 方法 :免疫组织化学法检测正常胃和胃癌组织中PCNA和VEGF的表达,并分析其与胃癌临床病理特征的相关性。 结果 :胃癌组织中PCNA、VEGF的阳性表达率分别为850%、683%,二者在正常胃组织中均为隐性表达。PCNA的表达与肿瘤分期、淋巴结转移有关(〖WTBX〗P lt;005),而与年龄、性别、肿瘤大小、组织分化程度无关(〖WTBX〗P gt;005);PCNA的表达与肿瘤分期、淋巴结转移有关(〖WTBX〗P lt;005),而与年龄、性别、肿瘤大小、组织分化程度无关(〖WTBX〗P gt;005)。PCNA和VEGF在胃癌中的表达呈正相关。 结论 :PCNA和VEGF在胃癌组织中的高表达促进了胃癌的发生发展。Abstract: Objective: To study the significance and relationship of expression of proliferating cell nuclear antigen(PCNA) and vascular endothelial growth factor (VEGF) in gastric cancer. Methods : The expression of VEGF and PCNA in normal gastric tissues and gastric cancer tissues were detected by immunohistochemistry (SP),and clinic pathological correlation with gastric cancer was analyzed. Results : The positive exression rates of PCNA and VEGF in gastric cancer were 850%、683%, respectively, while negative expression was shown in normal gastric tissues. It was found that the expressions of PCNA and VEGF were both in significant relation to TNM stages and lymph node metastasis (P lt;005), but in no relation to age, gender, diameter of tumor and tumor cell differentiation (P gt;005). The expressions of PCNA and VEGF were positively correlated with each other. Conclusion : It was indicated that the highlevel expressions of PCNA and VEGF might corporately accelerate the progression of gastric cancer.